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Abstract
Introduction: This study was performed to assess the early diagnostic, risk stratification, and prognostic value of
the angiopoietin-2/angiopoietin-1 ratio (Ang-2/Ang-1) and angiopoietin-1/tyrosine kinase with immunoglobulin-like
loop epidermal growth factor homology domain 2 ratio (Ang-1/Tie-2) and to compare these factors with procalcitonin
(PCT) and the Mortality in Emergency Department Sepsis (MEDS) score in patients with early sepsis in the emergency
department (ED).
Methods: Consecutive patients with sepsis (n = 440) were enrolled in this study. They fulfilled the systemic inflammatory
response syndrome (SIRS) criteria and were admitted to the ED of Beijing Chao-yang Hospital between August 2014
and February 2015. The control group consisted of 55 healthy blood donors. The patients were categorized into four
groups: SIRS, sepsis, severe sepsis, and septic shock. Serum Ang-1, Ang-2, Tie-2, and PCT were measured, and the MEDS
score was calculated upon ED arrival. The prognostic values of Ang-2/Ang-1, Ang-1/Tie-2, Ang-1, Ang-2, and Tie-2 were
compared with the PCT and MEDS scores. All patients were followed for 28 days.
Results: Upon admission, the median levels of the serum Ang-2 level and Ang-2/Ang-1 ratio increased and the serum
Ang-1 levels and Ang-1/Tie-2 ratios decreased with the severity of sepsis. The areas under the receiver operating
characteristic curves of the Ang-2/Ang-1 and Ang-1/Tie-2 ratios were greater than those of the Ang-1, Ang-2, and PCT
levels and MEDS scores in the diagnosis and prediction of 28-day mortality due to sepsis. Ang-2/Ang-1 was significantly
higher and Ang-1/Tie-2 was significantly lower in nonsurvivors than in survivors at the 28-day follow-up examination.
Ang-2/Ang-1, Ang-1/Tie-2, and MEDS score were found to be independent predictors of 28-day mortality in patients
with sepsis. The levels of serum Ang-1, Ang-2, and Tie-2 were positively correlated with each other. The ratios of
Ang-2/Ang-1 and Ang-1/Tie-2 were positively and negatively correlated, respectively, with the MEDS score in every
septic group.
Conclusions: The Ang-2/Ang-1 and Ang-1/Tie-2 ratios are valuable for risk stratification in patients with sepsis and are
associated with the poor clinical outcome of early sepsis in the ED.
Introduction
Sepsis continues to be a very significant cause of mortal-
ity. Sepsis with multiple organ dysfunction syndrome
(MODS) is the most catastrophic manifestation. In
addition, patients who develop severe sepsis or septic
shock have worse mortality than patients who do not de-
velop sepsis [1, 2]. Effective management and resource
allocation is difficult because of the inability to diagnose
the severity and predict the high risk of sepsis. Although
current biomarkers show great promise in indicating the
severity of sepsis, the highly variable and nonspecific
nature of the signs and symptoms of sepsis makes the
prospect of single biomarker classification less valuable.
Currently, it is of great significance to identify bio-
markers and combine them with clinical scoring systems
for risk stratification and evaluation of the prognosis of
sepsis.
Among the complex mechanisms and heterogeneous
nature of sepsis, widespread endothelial dysfunction plays
an extremely important role in the severity of sepsis and
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sepsis-induced MODS [1, 3, 4]. The endothelium is a key
target of sepsis-induced events, and the sepsis-activated
vascular endothelium is responsible for the increase in lu-
minal cell adhesion molecules, leukocyte recruitment,
vasomotor tone alteration, microvascular thrombosis for-
mation, and eventually diffuse capillary leakage [4, 5]. One
of the most important mechanisms activating endothelial
cells during sepsis is the endothelium-specific angiopoietin
(Ang) tyrosine kinase with the immunoglobulin-like loop
epidermal growth factor domain (Tie) ligand–receptor
system, which has a potential correlation with endothelial
injury severity. Ang-1, Ang-2, and Tie-2 play different
roles in mediating vascular quiescence and inflammation.
Ang-1 promotes vessel stability, suppresses inflammation,
and promotes endothelial cell survival by activating the
Tie-2 receptor complex [6–8], whereas Ang-2 destabilizes
blood vessels, potentiates inflammation, and promotes
proangiogenic effects, which result in vascular leakage and
organ dysfunction by initially blocking the Tie-2 receptor
[6, 9, 10]. The Tie-2 receptor is expressed and activated
throughout the quiescent adult endothelium [11], where
it promotes microvascular barrier function and anti-
inflammation [12]. Investigators have investigated Ang-1
and Ang-2 in various studies as biomarkers of sepsis se-
verity and mortality because of their roles in endothelial
activation and their convenient measurement in the ED.
Previous studies have shown that levels of Ang-1 and
Ang-2 are clinically informative prognostic biomarkers
of mortality in severe sepsis [13]. Ang-1 protects against
organ dysfunction in animal models of sepsis [14],
whereas Ang-2 is associated with sepsis severity and
multiple organ dysfunction in sepsis in vitro [15] and
in vivo [16]. However, in most of the previous studies,
evidence for the use of the Ang-2/Ang-1 and Ang-1/
Tie-2 ratios in predicting the severity and high mortality
in patients with early sepsis has been lacking. Given
these considerations, the aim of our present study was
to investigate the correlation of serum the Ang-2/Ang-1
and Ang-1/Tie-2 ratios with risk stratification and prog-
nostic evaluation of various degrees of early sepsis com-
pared with PCT levels and MEDS scores.
Material and methods
Patients
This study was approved by the human research ethics
committee of Beijing Chao-yang Hospital affiliated with
the Capital Medical University (Beijing, China), and signed
written informed consent forms were obtained from pa-
tients upon ED admission. The biological specimens and
clinical data sets were obtained from a prospective obser-
vational study of patients who had a suspected infection
with two or more criteria of systemic inflammatory re-
sponse syndrome (SIRS) and who were enrolled in the ED
of Beijing Chao-yang Hospital, which had an average of
260,000 visits annually during the period between August
2014 and January 2015. The patient records were an-
onymous and deidentified before analysis. The exclusion
criteria were (1) age <18 years old or >80 years old; (2)
pregnancy or breastfeeding; (3) neutropenia, defined as
<1000 neutrophils/mm3; (4) HIV infection; (5) hyperten-
sion or constantly taking angiotensin-converting enzyme
inhibitors, angiotensin II receptor antagonists, or renin in-
hibitors; (6) chronic intake of corticosteroids, defined as
any daily oral intake of 1 mg/kg or more of equivalent
prednisone for more than 1 month; (7) recent use of doses
of unfractionated or low-molecular-weight heparin; and
(8) lack of informed consent by the patients or their
relatives.
A total of 440 patients who were followed for 28 days
or until death were categorized on the basis of the 2001
Society of Critical Care Medicine/European Society of
Intensive Care Medicine/American College of Chest
Physicians/American Thoracic Society/Surgical Infection
Society International Sepsis Definitions Conference and
Surviving Sepsis Campaign guidelines [17, 18] into the fol-
lowing subgroups: SIRS (n = 107), sepsis (n = 176), severe
sepsis (n = 84), and septic shock (n = 73). The control
group included 55 healthy blood donors with no history
or clinical evidence of acute or chronic disease. They were
similar in age and sex to the experimental groups.
Sample collection and measurements
Most of the blood samples were obtained from blood
drawn for routine diagnostic procedures, and no add-
itional blood was obtained from the patients. Informed
consent was provided by the patients or their first-
degree relatives and by healthy control subjects before
blood collection. Within 15 min of arrival in the ED, a
5-ml sample of blood was collected from patients and
healthy donors in tubes containing ethylenediaminetet-
raacetic acid. The samples were immediately transferred
to the local central laboratory. The serum was stored at
−80 °C until further measurement.
Samples were analyzed by researchers who were blinded
to all patient data. Serum Ang-1, Ang-2, and Tie-2 were
measured in available samples upon admission using an
enzyme-linked immunosorbent assay (Abcam, Cambridge,
MA, USA). PCT levels were measured using an enzyme-
linked fluorescence immunoassay with a miniVIDAS im-
munoassay analyzer (bioMérieux, Durham, NC, USA). All
standards, controls, and test samples were assayed in du-
plicate. All measurements were performed according to
the manufacturers’ instructions.
Calculation of the MEDS score and APACHE II score
The MEDS score was calculated by summing the points
of nine variables: terminal illness, tachypnea or hypoxia,
septic shock, low platelet count, age >65 years, lower
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respiratory tract infection, nursing home resident, and
altered mental status [19]. The Acute Physiology and
Chronic Health Evaluation (APACHE) II score consisted
of measurements of the body temperature, mean arterial
pressure, heart rate, respiratory rate, oxygenation, arter-
ial pH, sodium, potassium, creatinine, hematocrit, white
blood cell count, Glasgow Coma Scale score, age, chronic
diseases, and surgical status, with a total possible score be-
tween 0 and 71 [20].
Statistical analyses
These results were presented as the mean standard devi-
ation or median range (interquartile range). Nonnormal
distribution of continuous variables was tested using the
Kolmogorov-Smirnov test and Mann–Whitney U test. In
patients, differences between survivors and nonsurvivors
were also compared using a nonparametric two-sided
Mann–Whitney U test. Comparisons between groups
are illustrated with box plot graphics, where the dotted
line indicates the median, the box represents the 25th–
75th percentiles, the horizontal lines show the minimum
and maximum values of the calculated nonoutlier values,
and the open circles indicate outlier values. To deter-
mine independent predictors of 28-day mortality, logistic
regression analysis was performed while adjusting for
age, sex, type of infection, and infection sites. A receiver
operating characteristic (ROC) curve was used to assess
the accuracy of the variables in prediction of 28-day mor-
tality. In addition, the comparisons of areas under the
ROC curves (AUCs) were analyzed using MedCalc version
11.6 software (MedCalc Software, Ostend, Belgium). Fur-
thermore, the optimal cutoff value for Ang-2/Ang-1 and
Ang-1/Tie-2 ratios to differentiate between survivors and
nonsurvivors was determined empirically from the ROC
curve using the Youden index [21]. Two-sided p values of
0.05 were considered statistically significant. Confidence
intervals (CIs) were reported at 95 %. Kaplan–Meier sur-
vival curves were constructed for patients to examine the
prognostic value of the Ang-2/Ang-1 and Ang-1/Tie-2 ra-
tios according to their levels at ED admission. The log-
rank test was used to compare survival rates between
groups. Finally, Spearman’s rank correlation coefficient
was calculated to describe correlations between Ang-1,
Ang-2, and Tie-2 levels, as well as Ang-2/Ang-1 ratio,
Ang-1/Tie-2 ratio, and MEDS score. All of the data were




A total of 440 patients and 55 healthy controls were en-
rolled in the study and the recruitment of patients into
the study is shown in Fig. 1. There were no significant
differences in age, sex, heart rate (HR), ratio of partial
pressure arterial oxygen to fraction of inspired oxygen,
infections between the five groups (healthy controls,
SIRS, sepsis, severe sepsis, and septic shock). There were
significant differences between groups in the APACHE
II and MEDS scores (p < 0.0001). The basic characteris-
tics, mediators and infections of the enrolled subjects
are listed in Tables 1 and 2.
Comparison of median Ang-1, Ang-2, and Tie-2 levels,
Ang-2/Ang-1 ratio, Ang-1/Tie-2 ratio, and MEDS score
Table 2 shows, for each study group, the median Ang-1,
Ang-2, and Tie-2 levels; Ang-2/Ang-1, and Ang-1/Tie-2
ratios; the PCT level; and the MEDS score. Figure 2 dis-
plays the Ang-1, Ang-2, and Tie-2 levels in each group.
Serum Ang-1, Ang-2, Tie-2, and PCT and the MEDS
score at ED admission were significantly different among
the groups. Compared with the healthy control group, the
Ang-2, Tie-2, PCT level, and MEDS score were signifi-
cantly higher, and Ang-1 level was lower, in patients with
SIRS, sepsis, severe sepsis, and septic shock (p < 0.0001).
Interestingly, the Ang-2/Ang-1 and Ang-1/Tie-2 ratios
were markedly different in sepsis, severe sepsis, and septic
shock compared with the control group (p < 0.0001).
Ang-2/Ang-1 and Ang-1/Tie-2 ratios in survivors and
nonsurvivors
The Ang-2/Ang-1 ratio was higher in survivors than in
nonsurvivors, whereas the Ang-1/Tie-2 ratio was lower
in survivors than in nonsurvivors (p < 0.0001) (Fig. 3).
Value of the Ang-2/Ang-1 and Ang-1/Tie-2 ratios and
MEDS scores for predicting 28-day mortality
The AUC of Ang-2/Ang-1 ratio for predicting 28-day
mortality in patients with sepsis was 0.845 higher than
PCT (0.732) and Ang-1 and Ang-2 levels (0.778 and
0.794, respectively) (all p < 0.05). The AUC of Ang-1/Tie-2
ratio for predicting 28-day mortality in patients with sepsis
was 0.808 higher than PCT (0.732) (p < 0.05). The AUC of
Ang-2/Ang-1 ratio for predicting 28-day mortality was
0.845, higher than that of MEDS score (0.826), but was
not statistically significant (p >0.05). The AUC of Ang-2/
Ang-1 ratio in combination with the MEDS score was
0.857, which was statistically significant compared with
MEDS score (0.826) (p < 0.05). The AUC of Ang-1/Tie-2
ratio in combination with MEDS score was higher than
MEDS score alone (0.844 vs. 0.826; p < 0.05).
The AUC for a combination of Ang-2/Ang-1 ratio,
MEDS score, and PCT was significantly higher than that
for PCT combined with MEDS score (0.900 vs. 0.829; p <
0.01). The AUC for a combination of Ang-1/Tie-2 ratio,
MEDS score, and PCT was also significantly higher than
that of PCT combined with MEDS score (0.894 vs.
0.829; p < 0.05). Among the prognostic factors studied,
the best rate for prediction of 28-day mortality was
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for a combination of Ang-2/Ang-1 and Ang-1/Tie-2
ratios, MEDS score, and PCT, which was significantly
higher than for each parameter alone (p < 0.01). All of
the data were analyzed using MedCalc version 11.6
software. The ROC curves of these biomarkers and
MEDS scores for predicting 28-day mortality among
the five groups are shown in Fig. 4.
Using an Ang-2/Ang-1 ratio cutoff value of 1.94 for
predicting 28-day mortality in patients with sepsis, the
sensitivity was 79.7 %, the specificity was 81.3 %, the
positive predictive value (PPV) was 78.4 %, the negative
predictive value (NPV) was 82.5 %, the positive likeli-
hood ratio (LR+) was 3.98, and the negative likelihood
ratio (LR−) was 0.31. Using an Ang-1/Tie-2 ratio cutoff
Fig. 1 CONSORT flow diagram of the study. SIRS systemic inflammatory response syndrome
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value of 30.0 for predicting 28-day mortality in patients
with sepsis, the sensitivity was 73.0 %, the specificity was
82.4 %, the PPV was 79.4 %, the NPV was 77.9 %, the
LR+ was 4.15, and the LR– was 0.33. The detailed re-
sults are presented in Tables 3 and 4.
Ang-2/Ang-1 ratio and MEDS score as independent
predictors of 28-day mortality
Age, sex, Ang-1, Ang-2, and Tie-2 levels, Ang-2/Ang-1
ratio, Ang-1/Tie-2 ratio, PCT, and MEDS score were in-
cluded in a multivariate logistic regression model to
determine the independent predictors of 28-day mortality.
Ang-2/Ang-1 (β = −0.013, odds ratio [OR] = 0.987, p <
0.0001), Ang-1/Tie-2 (β = −6.553, OR = 0.011, p = 0.004),
and MEDS score (β = 0.167, OR = 1.182, p < 0.0001) were
found to be independent predictors of 28-day mortality in
patients with sepsis (Table 5).
Survival
Using cutoff values determined by ROC curves, Kaplan–
Meier survival curves were established. Figure 5a illustrates
the Kaplan–Meier curves of 28-day survival stratified by
Table 1 Basic characteristics of the study population
Characteristics Control SIRS Sepsis Severe sepsis Septic shock p value
Number of subjects 55 107 176 84 73
Demographic data
Age (yr) 61 (54–71) 68 (56–76) 71 (59–78) 74 (61–78) 75 (65–78) 0.202
Male (%) 54.5 52.6 61.0 60.3 58.1 0.831
Physiological data
MAP (mmHg), mean ± SD 100 ± 19 110 ± 21 90 ± 15 89 ± 13 64 ± 14 0.042
HR (beats/min), mean ± SD 79 ± 22 103 ± 21 99 ± 15 105 ± 23 105 ± 23 0.339
PaO2/FIO2 ratio 306 (258–379) 300 (255–369) 293 (245–363) 235 (130–295) 213 (103–265) 0.098
APACHE II score 0 6.00 (3.00–8.00) 7.00 (6.07–9.00) 15.5 (10.0–22.0) 21.0 (16.1–29.0) <0.0001
MEDS score 0 5.00 (3.00–6.00) 7.00 (6.00–8.00) 19.0 (18.0–22.0) 25.0 (24.0–26.0) <0.0001
Abbreviations: SD standard deviation, SIRS systemic inflammatory response syndrome, APACHE Acute Physiology and Chronic Health Evaluation, MEDS Mortality in
Emergency Department Sepsis, MAP mean arterial pressure, HR heart rate, PaO2/FiO2 ratio of partial pressure arterial oxygen to fraction of inspired oxygen
Table 2 Mediators and infections of the study population
Control SIRS Sepsis Severe sepsis Septic shock p value
Number of subjects 55 107 176 84 73
Mediator levels
PCT (ng/ml) 0.11 (0.09–0.13) 0.64 (0.56–0.71) 1.20 (1.09–6.67) 7.97 (3.06–12.3) 13.2 (1.21–33.0) <0.0001
Ang-1 (ng/ml) 9.54 (7.56–10.89) 9.11 (5.67–11.2) 7.57 (6.78–8.75) 5.32 (4.56–6.24) 3.06 (0.99–7.45) <0.0001
Ang-2 (ng/ml) 3.41 (1.45–6.23) 5.42 (5.18–5.91) 13.0 (12.0–6.24) 18.7 (12.1–19.4) 15.7 (11.4–27.8) <0.0001
Tie-2 (ng/ml) 107.9 (92.1–129.3) 113.0 (99.8–189.9) 174.7 (134.2–220.4) 272.1 (176.5–358.4) 311.9 (149.9–415.2) <0.0001
Ang-2/Ang-1 ratio 0.49 (0.16–0.61) 0.73 (0.51–0.91) 1.73 (1.37–2.00) 3.42 (1.93–4.15) 5.14 (1.50–18.95) <0.0001
Ang-1/Tie-2 ratio (×103) 82.4 (68.3–98.0) 63.0 (40.6–84.4) 43.1 (34.9–62.2) 17.0 (11.5–28.8) 8.7 (1.8–41) <0.0001
Infection data (n)
Respiratory (lung) AECOPD (77) Pneumonia (121) Pneumonia (60) Pneumonia (50) 0.564
Asthma (9)
PE (2)
Intra-abdominal sites Pancreatitis (7) IAI (24) IAI (14) IAI (15) 0.558
Cerebral Stroke (8) Meningitis (15) Meningitis (5) Meningitis (6) 0.695
Urinary Pyelonephritis (10) Pyelonephritis (5) Pyelonephritis (2) 0.754
Other DKA (4) Skin/soft tissue infection (6)
28-day mortality, n (%) 0 15 (14.0) 32 (18.2) 36 (42.9) 45 (61.6) <0.0001
Missing data, n (%) 0 13 (10.8) 18 (9.3) 9 (9.7) 8 (9.9) 0.770
Abbreviations: SIRS systemic inflammatory response syndrome, PCT procalcitonin, Ang angiopoietin, Tie-2 tyrosine kinase with immunoglobulin-like loop epidermal
growth factor domain 2, AECOPD acute exacerbations of chronic obstructive pulmonary disease, PE pulmonary embolism, RI respiratory infection, IAI intraabdominal
infection, DKA diabetic ketoacidosis
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the admission levels of the Ang-2/Ang-1 ratio above and
below 1.94. The log-rank test confirmed the statistical sig-
nificance of Ang-2/Ang-1 (log-rank = 94.42; p < 0.0001).
Similarly, Kaplan–Meier survival analysis also showed that
patients with sepsis with a serum Ang-1/Tie-2 ratio lower
than 30.0 had a higher probability of survival at 28 days,
as shown in Fig. 5b (log-rank = 100.48; p < 0.0001).
Correlation of serum levels of Ang-1 and Ang-2 with
serum Tie-2 levels and Ang-2/Ang-1 ratio, Ang-1/Tie-2
ratio with MEDS score
Spearman’s correlation analysis of Ang-1 and Ang-2 with
Tie-2 showed correlation coefficients of 0.574, −0.613,
and 0.637, respectively (all p < 0.0001). The correlation co-
efficients between Ang-2/Ang-1, Ang-1/Tie-2, and MEDS
score were 0.527 and −0.555, which suggested a positive
and negative correlation, respectively (all p < 0.0001).
Discussion
It is important to identify useful biomarkers to improve
early diagnosis and risk stratification, particularly in the
early stages of sepsis. In our study, patients with sepsis
presented with significantly decreased serum Ang-1 levels
and Ang-1/Tie-2 ratios and markedly elevated serum
Ang-2 and Tie-2 levels and Ang-2/Ang-1 ratios measured
at admission [13, 22, 23]. The Ang-2/Ang-1 and Ang-1/
Fig. 2 The serum levels of Ang-1 (a), Ang-2 (b), and Tie-2 (c) in healthy control individuals and in patients with systemic inflammatory response
syndrome, sepsis, severe sepsis, and septic shock upon emergency department admission. Ang angiopoietin, SIRS systemic inflammatory response
syndrome, Tie-2 tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2
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Fig. 3 Ang-2/Ang-1 (a) and Ang-1/Tie-2 (b) ratios at admission in survivor and nonsurvivor groups of patients with sepsis at 28-day follow-up.
Lines denote he median values, boxes represent 25th–75th percentiles, and whiskers indicate the range. Ang angiopoietin, Tie-2 tyrosine kinase with
immunoglobulin-like loop epidermal growth factor homology domain 2
Fig. 4 ROC curves for predicting 28-day mortality in patients with sepsis. a AUCs for predicting 28-days mortality: Ang-2/Ang-1 ratio in combination
with MEDS score = 0.857 (blue line), Ang-1/Tie-2 ratio in combination with MEDS score = 0.844 (pink line). b Similarly, AUCs for predicting
28-days mortality: Ang-2/Ang-1 ratio in combination with MEDS = 0.857 (purple line), Ang-1/Tie-2 ratio in combination with MEDS score = 0.844
(green line), PCT in combination with MEDS score = 0.829 (blue line), a combination of Ang-2/Ang-1 ratio, MEDS score, and PCT = 0.900 (pink line),
a combination of Ang-1/Tie-1 ratio, MEDS score, and PCT = 0.894 (yellow line), a combination of Ang-2/Ang-1, Ang-1/Tie-1 ratios, MEDS score,
and PCT = 0.925 (red line). Ang angiopoietin, AUC area under the receiver operating characteristic curve, MEDS Mortality in Emergency Department
Sepsis, PCT procalcitonin, ROC receiver operating characteristic, Tie-2 tyrosine kinase with immunoglobulin-like loop epidermal growth factor
homology domain 2
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Tie-2 ratios are considered to be valuable biomarkers in
rapid risk stratification and prognosis for 28-day mortality
in patients with sepsis in the ED.
Researchers in two other studies to date have reported
Ang-2/Ang-1 ratios in patients with sepsis, and the evi-
dence of similar Ang-1/Tie-2 ratios has been lacking. In
the first study, Ricciuto et al. found that the admission
levels of Ang-2/Ang-1 ratio at baseline were not robust
markers for 28-day mortality in patients with severe sep-
sis [23]. In the second study, Wang et al. showed that
the Ang-2/Ang-1 ratio was not a promising marker for
severity or outcomes in pediatric patients with severe
sepsis and less effective than using Ang-1 and Ang-2
alone [24]. The discrepancy between our observations
and those of Ricciuto et al. may relate to the fact that
Ang-2/Ang-1 ratio was measured in plasma in their
study, not in serum as in ours. Also, our study popula-
tion was consecutively collected and comprised a large
number of subjects (n = 495), whereas only 70 patients
with severe sepsis were enrolled in their patient cohort.
Their study’s small sample size might have been respon-
sible for an underpowered or erroneous multivariable ana-
lysis lacking differences between the groups. In addition,
our study population contained various degrees of early
sepsis and was well divided into control (n = 55), SIRS
(n = 107), sepsis (n = 176), severe sepsis (n = 84), and sep-
tic shock (n = 73), whereas their study cohort included
merely patients with severe sepsis divided into survivors
(n = 39) and nonsurvivors (n = 31) at 28 days and did not
include healthy individuals. The discrepancies between
our results and those of Wang et al. may be the greatly
different pathophysiology between critically ill pediatric
patients and adults, along with the complex and heteroge-
neous nature of sepsis. Moreover, the relatively small
number of pediatric patients with severe sepsis sampled
(n = 45) might have been another reason resulting in a
lack of differences between the groups.
In the developed vasculature, Ang-1 protects against
vascular leakage, whereas Ang-2 promotes increased
vascular permeability. Ang-1 and Ang-2 appear to act as
an agonist–antagonist pair mediating capillary endothe-
lium leakage (i.e., Ang-2/Ang-1). The higher the Ang-1/
Ang-2 ratio is, the more severe the capillary endothelial
damage. In addition, Ang-1 has been proposed to be ne-
cessary for the maintenance of vascular barrier function
via its interaction with Tie-2 in blood vessels. As a default
Table 3 AUCs for predicting 28-day mortality in patients with early sepsis
Variable AUC Standard error p value 95 % CI
Lower limit Upper limit
28-day mortality Ang-1 0.778 0.024 0 0.732 0.824
Ang-2 0.794 0.018 0 0.750 0.837
Tie-2 0.803 0.024 0 0.756 0.849
Ang-2/Ang-1 0.845 0.018 0 0.810 0.880
Ang-1/Tie-2 0.808 0.023 0 0.763 0.853
PCT 0.732 0.024 0 0.685 0.780
MEDS score 0.826 0.021 0 0.785 0.866
Ang-2/Ang-1+MEDS score 0.857 0.018 0 0.821 0.893
Ang-1/Tie-2+MEDS score 0.844 0.020 0 0.805 0.883
PCT+MEDS score 0.829 0.020 0 0.790 0.869
Ang-2/Ang-1+PCT+MEDS score 0.900 0.017 0 0.866 0.934
Ang-1/Tie-2+PCT+MEDS score 0.894 0.016 0 0.862 0.926
Ang-2/Ang-1+Ang-1/Tie-2+PCT+MEDS score 0.925 0.013 0 0.898 0.951
Abbreviations: Ang angiopoietin, AUC area under the receiver operating characteristic curve, CI confidence interval, MEDS Mortality in Emergency Department
Sepsis, PCT procalcitonin, Tie-2 tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2
Table 4 Performance of multivariable models for predicting 28-day mortality in patients with early sepsis
Variable Cutoff Sensitivity (%) Specificity (%) PPV (%) NPV (%) LR+ LR−
28-day mortality Ang-2/Ang-1 1.94 79.7 81.3 78.4 82.5 3.98 0.31
Ang-1/Tie-2 (×103) 30.0 73.0 82.4 79.4 77.9 4.15 0.33
PCT 5.27 62.3 84.9 60.3 85.4 2.03 0.22
MEDS score 14.5 70.6 76.3 56.2 90.7 3.35 0.27
Abbreviations: Ang angiopoietin, LR− negative likelihood ratio, LR+ positive likelihood ratio, MEDS Mortality in Emergency Department Sepsis, NPV negative predictive
value, PCT procalcitonin, PPV positive predictive value, Tie-2 tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2
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pathway, constitutive Ang-1–Tie-2 interactions promote
endothelial cell migration, proliferation, survival, and dif-
ferentiation and regulate endothelial barrier integrity and
stability [25, 26]. A lower Ang-1/Tie-2 ratio indicates a
stronger defense against capillary endothelial damage.
Taken together, the increase in the Ang-2/Ang-1 ratio and
the decrease in the Ang-1/Tie-2 ratio demonstrate that
destruction of the capillary endothelium is greater than
the stability in the deterioration of sepsis. Thus, high ad-
mission serum Ang-2/Ang-1 ratio and low admission
serum Ang-1/Tie-2 ratio identify the severity of sepsis in
patients at the onset of early sepsis in the ED.
The Ang-2/Ang-1 and Ang-1/Tie-2 ratios were superior
to the absolute Ang-1 and Ang-2 levels for prognostic
purposes in critical care [27, 28] and had significant diag-
nostic and prognostic value for 28-day mortality. Our re-
sults show that an initial relative deficiency of Ang-1 level
associated with a sharp increase in Ang-2 level is associ-
ated with risk stratification and clinically poorer outcome
in patients with sepsis. The AUC of Ang-2/Ang-1 ratio for
predicting 28-day mortality in patients with sepsis was
higher than the AUCs for Ang-1 and Ang-2 levels. On the
one hand, Chong and colleagues [29] recently determined
that a “relative deficiency” of Ang-1 levels and a “relative
adequacy” of Ang-2 levels most likely indicate the degree
of capillary endothelial injury in sepsis and in patients with
sepsis with high mortality arising from a more severe de-
gree of injury to the capillary endothelium, resulting in










Lower limit Upper limit
28-day mortality Ang-1 −0.063 0.081 0.605 1 0.157 0.939 0.802 1.100
Ang-2 0.067 0.022 8.996 1 0.003 1.069 1.023 1.117
Tie-2 0.002 0.002 0.807 1 0.269 1.002 0.998 1.072
Ang-2/Ang-1 −0.013 0.043 0.094 1 0.026 0.987 0.909 1.072
Ang-1/Tie-2 −6.553 7.793 0.707 1 0.024 0.011 0.009 0.013
PCT −0.006 0.019 0.101 1 0.325 0.994 0.958 1.032
MEDS score 0.167 0.028 35.637 1 0.009 1.182 1.119 1.249
Constant 3.901 1.585 6.058 1 0.714 0.432
Abbreviations: Ang angiopoietin; CI confidence interval, MEDS Mortality in Emergency Department Sepsis, PCT procalcitonin, Tie-2 tyrosine kinase with immunoglobulin-
like loop epidermal growth factor homology domain 2
Fig. 5 a Kaplan–Meier survival curves show that patients with sepsis with Ang-2/Ang-1 ratios higher than 1.94 had a lower probability of survival
at 28 days (log-rank = 94.42; p < 0.0001) compared with patients with lower levels. b Similarly, patients with sepsis with Ang-1/Tie-2 ratios lower
than 0.03 had a lower probability of survival at 28 days (log-rank = 100.48; p < 0.0001) than patients with lower levels. Ang angiopoietin, Tie-2
tyrosine kinase with immunoglobulin-like loop epidermal growth factor homology domain 2
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relative changes of Ang-1 and Ang-2. Thus, the ratio be-
tween these two contrasting angiogenesis factors may be
capable of determining the fate of capillary endothelial
cells, and Ang-2/Ang-1 ratio is likely to be a strong bio-
marker of sepsis mortality. On the other hand, in in vivo
and vitro studies, Mofarrahi and colleagues found that
lipopolysaccharide administration downregulates Ang-1
expression and functionally inhibits the Ang-1/Tie-2 re-
ceptor pathway, resulting in an imbalance of endothelial
barrier integrity and stability and subsequent organ dys-
function. This is the main reason for the use of the Ang-
1/Tie-2 ratio as a prognostic biomarker of sepsis [26].
Currently, PCT is the most studied and promising sep-
sis biomarker for diagnosis, risk stratification, evaluation
of prognosis, and therapy monitoring [30]. Previous
studies of the utility of PCT have been focused mainly
on their diagnostic value for bacterial infection and are
not a specific indicator of all types of infection in sepsis
[31]. A substantial number of studies have challenged
the prognostic role of PCT [32]. In addition, the MEDS
score is more suitable than the other severity scoring
systems for predicting mortality among patients with
sepsis in the ED, despite the controversial value of clin-
ical application [33]. In our study, the PCT level and
MEDS score were chosen as a variable to compare with
the Ang-2/Ang-1 and Ang-1/Tie-2 ratios.
Because there are advantages and disadvantages of
biomarkers and scoring systems in the prognosis of sep-
sis, the combination between biomarkers with severity
scoring systems can overcome their limitations and im-
prove the accuracy of prognosis. In our study, the com-
bination of the Ang-2/Ang-1 and Ang-1/Tie-2 ratios
with the MEDS score was more effective than that of
PCT or the MEDS score alone in predicting 28-day mor-
tality. PCT was used merely to support the diagnosis of
bacterial infection, but it exhibited no discriminative
power for the prediction of mortality in early sepsis. Al-
though the MEDS score is regarded as an easy and reli-
able method for predicting mortality in patients with a
suspected infection, the discriminative ability of the com-
bination of PCT and the MEDS score in the prognostic
evaluation of sepsis is still limited. However, in a more
comprehensive aspect, the combination of the Ang-2/
Ang-1 and Ang-1/Tie-2 ratios with the MEDS score indi-
cates the degree of general capillary endothelial damage
and pathological condition of patients with sepsis and re-
flects the pathophysiological mechanism of widespread ca-
pillary endothelium and the risk of short-term mortality of
patients in early sepsis. Taken together, the Ang-2/Ang-1
and Ang-1/Tie-2 ratios enhanced the accuracy of PCT
and the MEDS score in prognostic evaluation.
In addition, there were significant close correlations
between the Ang-1, Ang-2, and Tie-2 levels [6] and be-
tween the Ang-2/Ang-1 or Ang-1/Tie-2 ratios and the
MEDS score. Similar associations between the Ang-2/
Ang-1 or Ang-1/Tie-2 ratios and the MEDS score in
critically ill patients have not been reported previously.
The survival curves clearly illustrated the optimized in-
formation provided by the use of the Ang-2/Ang-1 or
Ang-1/Tie-2 ratios. Both markers above or below their
respective cutoff value indicate a high risk of death.
Limitations
Some limitations of this study merit consideration. First,
convenience sampling or the subjective inclusion criter-
ion of “suspicion of infection” may have introduced bias
into the clinical portion of this work. Second, the patient
information on pathogenic evidence and treatment pref-
erences was not considered in the initial study. Third,
comparisons of the Ang-1, Ang-2, and Tie-2 levels be-
fore and after treatment were not performed during the
patients’ stay in the ED. Fourth, the complicated under-
lying diseases might have had an effect on the results.
Conclusions
Serum Ang-2/Ang-1 and Ang-1/Tie-2 ratios are inde-
pendent predictors of 28-day mortality in patients with
sepsis in the ED. The serum Ang-2/Ang-1 and Ang-1/Tie-
2 ratios are associated with risk stratification and prognos-
tic evaluation of sepsis and are more valuable predictors
of 28-day mortality than PCT and MEDS score.
Key messages
 The serum Ang-2/Ang-1 and Ang-1/Tie-2 ratios were
good biomarkers for reflecting the severity of sepsis.
 The serum Ang-2/Ang-1 and Ang-1/Tie-2 ratios were
superior to PCT and MEDS score for predicting
28-day mortality in patients with sepsis in the ED.
 The serum Ang-2/Ang-1 and Ang-1/Tie-2 ratios
and MEDS score were all independent predictors of
28-day mortality in patients with sepsis.
 The serum Ang-2/Ang-1 or Ang-1/Tie-2 ratios, in
combination with PCT and MEDS score, enhanced
the predictive accuracy of 28-day mortality in
patients with sepsis.
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